Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Fresenius Kabi Introduces Cancer Copay Scheme For Generics
Some Patients Could Find Their Monthly Costs Entirely Eliminated
Apr 21 2022
•
By
Chloe Kent
Fresenius Kabi says it has the most comprehensive generic injectable oncology portfolio in the US • Source: Alamy
More from Generics
More from Products